BG, Varuni2023-08-092023-08-092023-07BG Varuni. An Open-labeled Clinical Study to Evaluate the Safety and Efficacy of “Anuloma DS” in Improving Constipation. Indian Journal of Clinical Practice. 2023 Jul; 34(2): 14-220971-0876http://imsear.searo.who.int/handle/123456789/222136Background: Constipation is a common gastrointestinal problem in the general population. Despite a plethora of well-established and safe treatment options, the improvement is not satisfactory for many patients. This has prompted interest in alternative therapeutic strategies for constipation. Methods: This open-label, non-comparative single-arm clinical study evaluated the efficacy and safety of the polyherbal formulation “Anuloma DS”, 1 tablet daily at bedtime, in improving bowel movements in 30 adult patients with functional constipation. Patients were evaluated at baseline (Visit 1, Day 0) and follow-ups during Visit 2 (Day 7 ± 2), Visit 3 (Day 14 ± 2) and Visit 4 (End of the Study) at Day 30 ± 2. Results: There was a significant increase in the mean of spontaneous bowel movement every week from day 7 to days 14 and 30. All constipation symptoms such as abdominal bloating (aadmana), abdominal pain/discomfort (aanaha), feeling of incomplete evacuation and straining during passing stool improved significantly as did the SGA and the PGA scores. Conclusion: Anuloma DS is highly effective for the treatment of chronic functional constipation. No treatment-related side effects were reported by the study participants.Chronic functional constipationpolyherbalspontaneous bowel movementSGA scorePGA scoreJournal ArticleIndiaConsulting Ayurveda Physician Ayurveda Clinic 164, 3rd Cross, Hanumantha Nagar, Bengaluru - 560 019, Karnataka, India E-mail:varuni.ayurlife@gmail.com